Femasys Inc FEMY:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/19/22 EDT
2.00quote price arrow down-0.01 (-0.50%)
Volume
30,452
52 week range
1.26 - 8.40
Loading...
  • Open1.97
  • Day High2.08
  • Day Low1.87
  • Prev Close2.01
  • 52 Week High8.40
  • 52 Week High Date08/31/21
  • 52 Week Low1.26
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap23.62M
  • Shares Out11.81M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-47.82

KEY STATS

  • Open1.97
  • Day High2.08
  • Day Low1.87
  • Prev Close2.01
  • 52 Week High8.40
  • 52 Week High Date08/31/21
  • 52 Week Low1.26
  • 52 Week Low Date06/16/22
  • Market Cap23.62M
  • Shares Out11.81M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-47.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.86
  • P/E (TTM)-2.33
  • Fwd P/E (NTM)-1.99
  • EBITDA (TTM)-9.579M
  • ROE (TTM)-39.14%
  • Revenue (TTM)1.15M
  • Gross Margin (TTM)65.63%
  • Net Margin (TTM)-883.09%
  • Debt To Equity (MRQ)4.88%

EVENTS

  • Earnings Date11/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Femasys Inc

There is no recent news for this security.

Profile

MORE
Femasys Inc. is a biomedical company. The Company is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery...
Charles Larsen
Non-Executive Independent Chairman of the Board
Kathy Lee-Sepsick
President, Chief Executive Officer, Director
Dov Elefant
Chief Financial Officer
Lexy Kelley M.D.
Vice President - Clinical and Medical Affairs
Gary Thompson
Vice President of Finance and Administration
Address
3950 JOHNS CREEK COURT, SUITE 100
Suwanee, GA
30024
United States

Top Peers

SYMBOLLASTCHG%CHG
CANF
Can Fite Biopharma Ltd
0.89+0.0046+0.52%
CYTH
Cyclo Therapeutics Inc
2.58-0.08-3.01%
GOVX
GeoVax Labs Inc
1.73-0.24-12.18%
IKT
Inhibikase Therapeutics Inc
0.76-0.0421-5.2487%
IDRA
Idera Pharmaceuticals Inc
0.4301+0.0051+1.20%